Cowealth Medical Holding Co., Ltd. (TPEX:4745)
18.75
-0.30 (-1.57%)
Apr 20, 2026, 12:35 PM CST
Cowealth Medical Holding Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -246.56 | 0.63 | 49.11 | 94.12 | 139.46 |
Depreciation & Amortization | 42.35 | 44.34 | 51.48 | 55.03 | 67.03 |
Other Amortization | 7.72 | 6.61 | 3.55 | 2.26 | 2.83 |
Loss (Gain) From Sale of Assets | 0.01 | -1.74 | -0.63 | 0.79 | 0.02 |
Loss (Gain) From Sale of Investments | -1.19 | -1.82 | -17.58 | -7.5 | - |
Loss (Gain) on Equity Investments | 1.33 | -0.64 | -0.5 | -0.11 | 0.07 |
Provision & Write-off of Bad Debts | -95.84 | -6.09 | -20.65 | 20.27 | 29.32 |
Other Operating Activities | -71.54 | 92.17 | 133.92 | 192.42 | 58.3 |
Change in Accounts Receivable | 294.18 | -82.67 | 109.86 | -805.97 | -114.88 |
Change in Inventory | -69.99 | 38.83 | 181.24 | -53.78 | -186.68 |
Change in Accounts Payable | 13.53 | -35.12 | -65.77 | 233.96 | -56.76 |
Change in Unearned Revenue | -3.41 | 4.3 | -1.64 | -51.1 | - |
Change in Other Net Operating Assets | 144.94 | 410.65 | -377.37 | 52.03 | -57.08 |
Operating Cash Flow | 15.53 | 469.43 | 45.02 | -267.59 | -118.38 |
Operating Cash Flow Growth | -96.69% | 942.66% | - | - | - |
Capital Expenditures | -9.07 | -57.45 | -206.37 | -18.68 | -34.54 |
Sale of Property, Plant & Equipment | 0.63 | 3.22 | 0.77 | 1.39 | 0.13 |
Divestitures | 431.94 | - | - | - | - |
Sale (Purchase) of Intangibles | -5.63 | -4.9 | -30.13 | -7.69 | -2.12 |
Investment in Securities | -554.3 | -22.28 | 113.23 | -253.94 | 7.21 |
Other Investing Activities | -37.61 | 26.56 | -50.78 | 7.92 | 15.81 |
Investing Cash Flow | -174.03 | -54.86 | -173.28 | -271 | -13.51 |
Short-Term Debt Issued | 0.08 | - | 8.26 | - | 27.24 |
Long-Term Debt Issued | 20 | - | - | - | - |
Total Debt Issued | 20.08 | - | 8.26 | - | 27.24 |
Short-Term Debt Repaid | - | -82.25 | - | -191.13 | - |
Long-Term Debt Repaid | -19.7 | -48.34 | -56.11 | -61.03 | -111.01 |
Total Debt Repaid | -19.7 | -130.59 | -56.11 | -252.15 | -111.01 |
Net Debt Issued (Repaid) | 0.38 | -130.59 | -47.85 | -252.15 | -83.78 |
Common Dividends Paid | - | -30.98 | -123.92 | -116.17 | -92.94 |
Other Financing Activities | -122.61 | -77.35 | -144.72 | 1,434 | -21.84 |
Financing Cash Flow | -122.23 | -238.92 | -316.48 | 1,066 | -198.56 |
Foreign Exchange Rate Adjustments | 41.4 | 172.45 | -103.93 | 13.22 | -38.04 |
Net Cash Flow | -239.34 | 348.11 | -548.66 | 540.71 | -368.48 |
Free Cash Flow | 6.46 | 411.98 | -161.34 | -286.27 | -152.91 |
Free Cash Flow Growth | -98.43% | - | - | - | - |
Free Cash Flow Margin | 0.22% | 9.83% | -3.35% | -5.09% | -2.97% |
Free Cash Flow Per Share | 0.08 | 5.32 | -2.08 | -3.69 | -1.97 |
Cash Interest Paid | 22.77 | 29.49 | 34.6 | 24.56 | 21.84 |
Cash Income Tax Paid | 83.66 | 56.25 | 135.4 | 131.71 | 166.45 |
Levered Free Cash Flow | 409.69 | 341.51 | -132.81 | -455.38 | -179.74 |
Unlevered Free Cash Flow | 423.89 | 359.59 | -111.1 | -439.78 | -164.5 |
Change in Working Capital | 379.25 | 335.98 | -153.67 | -624.87 | -415.4 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.